Kai Shang

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University · ORCID：0000-0001-6393-0879

发表论文 53 篇 · 总被引 322 次 · h-index 12

代表论文

• CD38‐Specific CAR Integrated into CD38 Locus Driven by Different Promoters Causes Distinct Antitumor Activities of T and NK Cells (2023 · Advanced Science · 被引 29)
• Inserting EF1α-driven CD7-specific CAR at CD7 locus reduces fratricide and enhances tumor rejection (2023 · Leukemia · 被引 26)
• Deep learning-based automatic ASPECTS calculation can improve diagnosis efficiency in patients with acute ischemic stroke: a multicenter study (2024 · European Radiology · 被引 22)
• Balancing activation and co-stimulation of CAR tunes signaling dynamics and enhances therapeutic potency (2022 · Molecular Therapy · 被引 18)
• Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses (2025 · Nature Biomedical Engineering · 被引 15)
• Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non–small-cell lung cancer with an EGFR/TP53 co-mutation (2022 · BMC Cancer · 被引 13)